Product name | Recombinant SARS-CoV-2 3C-like Proteinase Protein |
---|---|
Catalog No. | RP01270LQ |
Description | Recombinant SARS-CoV-2(2019-nCoV) 3C-like Proteinase is produced by E. coli expression system. The target protein is expressed with sequence (Ser1-Gln306) of SARS-COV-2(2019-nCoV) 3C-like Proteinase (Accession #YP_009725301.1) fused with an initial Met, a 6×His, Avi tag at the N-terminus. |
Purity | > 95% by SDS-PAGE. |
Endotoxin | < 1.0 EU/μg of the protein by LAL method. |
Formulation | Supplied as a 0.22 μm filtered solution in 20mM HEPES, 120mM NaCl, 10% Glycerol, 2mM TCEP, pH7.4Contact us for customized product form or formulation. |
Species | SARS-CoV-2 |
Calculated MW | 36.9kDa |
Synonym | 3CLpro; NSP1; NSP10; NSP12; NSP13; NSP14; NSP15; NSP16; NSP2; NSP3; NSP4; NSP6; NSP7; NSP8; NSP9 |
---|---|
Expressed Host | E. coli |
Tag | N-His&Avi |
Gene ID | 43740578 |
Storage | This product is stable at ≤ -70°C for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature.Avoid repeated freeze-thaw cycles. |
---|
Submit your question about RP01270LQ below and we will get back to you within one business day.
Alternatively, call us at 888.754.5670.
* For research use only. Not for therapeutic or diagnostic purposes.